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ABSTRACT

Segura, Jason M. PhD., Purdue University, December 2016. Investigating the
Effects of pH On Alphaviral E3-E2 Glycoprotein Association, Organization, and
Cellular Tropism. Major Professor: David A. Sanders.

In alphaviruses the role of E3 is required in protecting the fusion peptide
region of E1 during intracellular transport. Throughout viral processing, the
association of E2 and E3 is required for the successful trafficking and
incorporation of E1 into the mature virion. This E3-E2 association has been
observed to extend to mature virions in the solved structure for the envelope of
Semliki Forest virus (SFV) and supported by the solved structure for the entire
Venezuelan equine encephalitis virion (VEEV) with exclusive contacts being
made between E3-E2. Immunization with monoclonal antibodies against VEEV
E3 provided protection for mice challenged by lethal doses of VEEV and
suggests potential new targets for antibody neutralization, but it is currently
unclear if E3 is retained on mature VEEV virus. Using non-replicating expression
systems that avoid virus-culturing artifacts, we discovered that Moloney murine
leukemia virus or baculovirus pseudotyped with the alphavirus envelope spike
complex of VEEV demonstrates a pH-dependent retention of E3 on mature virus
for both mammalian cells and insect cells through indirect-immunofluorescence
assays and neutralization studies using polyclonal antibodies against VEEV E3.

xii
In studies investigating the impacts of retaining the E3 glycoprotein on
mature virus outside of a host cell, we found this retention of E3 decreases
receptor-mediated entry of cell targets that can be rescued on cells containing
heparan sulfate suggesting viruses containing E3 on mature envelopes can
utilize the E3 protein as an attachment factor. We utilized a method for
downregulating the cell-surface expression of the natural resistance-associated
macrophage protein (NRAMP2), a definitive receptor for the prototypic alphavirus
Sindbis (SIND), on cellular targets. We observed a significant decrease in entry
of VEEV versus control Ross River (RRV) virus that does not utilize NRAMP2.
This inhibition can be rescued with binding to heparan sulfate by VEEV retaining
E3. Together, these data suggest that the E3 glycoprotein protects the fusion
region of E1 on budded, mature virus dependent on the pH of the extracellular
environment. This association potentially serves a role as an attachment factor
on virus and presents new binding sites for protein interactions and potential
inhibition.
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CHAPTER 1. ALPHAVIRUS INTRODUCTION

1.1. Introduction
Alphaviruses are enveloped positive-sense RNA viruses that belong to the
family Togaviridae and are also known as arboviruses for their modes of
transmission (Strauss 1994; Sourisseau 2007; Cavrini 2009). Alphaviruses
contain over 25 individual species of varying sequence similarity including the
well-studied, prototypic members Semliki Forest (SFV) and Sindbis (SIND) as
well as Ross River (RRV), Chikungunya (CHIKV), and Venezuelan Equine
Encephalitis (VEEV). Further designation places these species into
geographically classified clades of Old World or New World arboviruses
characterized by a considerable range of illnesses including long lasting
symptoms of arthralgia or debilitating encephalitis, respectively (Jose 2009).
Repeated outbreaks of these alphavirus species in countries within Asia,
Africa, South America, and emergence in Europe and North America
demonstrate not only epidemic occurrences, but also an increasing viral capacity
to extend outside endemic territories (Chevillon 2007). Overall, these pathogens
impact the health and economic stability within affected regions due to the
prolonged symptoms experienced by those infected, and considering the global
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distribution of the various species, alphaviruses pose a significant, ongoing
health risk (Figure 1). Furthermore, the classification of VEEV as a bioterrorism
agent and the absence of any alphaviral vaccine underscore the importance of
understanding the entry and replication mechanisms of these viruses.

Figure 1. Global Distribution of Selected Alphavirus Species
Geographical distribution of alphavirus members is further designated to Old
World vs. New World clades. New World viruses within the Americas
demonstrate pathologies of encephalitis whereas Old World viruses cause
arthralgia and myalgia. Map shows major endemic locations of recorded
outbreaks of both clades according to the World Health Organization.
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1.2. Viral Genome & Structure
Alphaviruses possess a single-stranded, positive sense RNA (+ssRNA)
genome of approximately 11.8kb (Figure 2). The genomic RNA is characterized
E\DFDSSHG¶WHUPLQXVDQGFRQWDLQVWKHQRQVWUXFWXUDO protein-coding genes for
nsP1 ± 4 LQWKH¶SUR[LPDOUHJLRQ7KH¶HQGRIWKHJHQRPLF51$LVSROyadenylated and is transcribed via a minus strand intermediate to yield a 26S subgenomic RNA responsible for 5 structural components of the virion as the capsid,
pE2 (precursor containing E2 and E3), 6K, and E1 proteins (Solignat 2009).
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30 kDa capsid protein that associates to form pentamers and hexamers (Parades
1992). The viral envelope contains 80 glycoprotein spikes that mediate entry into
the cell (Kielian 2000). The spike is comprised of a trimer of heterodimers of the
entry proteins E1 and E2. The E1 and E2 glycoproteins each have a
transmembrane region and interact to create a rigid structure across the
membrane that exhibits the T=4 icosahedral symmetry common to alphaviruses
(Von Bornsdoff 1975; Vogel 1986; Fuller 1987; Parades 1993). E1 lies at the
base of the spike forming a lattice on the virus surface (Lescar 2001). In contrast,
E2 extends upward from the lattice framework, appearing leaf-like (Zhang 2002).
The fusion peptide, required for membrane fusion and entry, is found in E1,
whereas E2 contains the receptor binding site responsible for recognizing both
mammalian and insect host cell receptors and a C-terminal region that interacts
with the nucleocapsid core through its transmembrane domain (Smith 1995;
Mukhopadhyay 2006).
The E3 glycoprotein is found in all species of the alphavirus genera with
varying degrees of sequence similarity, however the exact function of E3 is not
fully understood. There is evidence that the presence of E3 is required for the
successful maturation of the virus envelope proteins throughout the secretory
pathway (Lobigs 1990; Parrott 2009; Uchime 2013). Replacement of E3 with a
signal sequence causes a loss of E1 at the site of assembly and structural
studies demonstrate a potential interaction between E1 and E3 (Lobigs 1990, Wu
2008). This interaction might not only be important for targeting E1 to the
membrane, but it may also provide a stabilizing influence within the varying pH
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ranges found in the Golgi itself, preventing premature exposure of the fusion
loop. This is supported by evidence indicating that in VEEV and other
alphaviruses, cleavage mutants were incapable of initiating entry into susceptible
cells (Wahlberg 1989, 1992; Lobigs 1990, 1990). Observations with cleavage
mutants presenting E3 on mature SIND virus have been shown to bind heparan
sulfate moieties on the cell as well as offer new antigenic determinants for
neutralization in VEEV (Klimstra 1999; Parker 206MऺEHUJ2011). The
possibility of an E2-E3 association on mature virus is supported by the solved
structures of SFV and recently for VEEV at 4.4Å resolution suggesting that the
retention of E3 on the viral envelope is an electrostatic association in a low-pH
environment (6MऺEHUJ=KDQJ).
The increasing evidence for E3 presented on the virus surface adds
another variable to the conformational changes the viral glycoproteins must
undergo to mediate receptor binding and membrane fusion and presents an
opportunity to investigate another potential mechanism for neutralizing these
viruses. (FRQVLVWVRIWZRȕ-VWUDQGVDQGWKUHHĮ-helices linked in the case of
CHIKV by three disulfide bonds. In pE2, E3 stabilizes the domain B in E2 so that
a groove is created between domain B and domain A in which the fusion loop of
E1 is hidden. Disruption of this groove occurs when E3 is cleaved from E2
allowing the fusion loop of E1 to become exposed (Voss 2010). The exact fate of
E3 after cleavage is unknown, however E3 is reported to remain associated with
SFV on the mature virus surface (Garoff 1974), but to be absent from other
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alphaviruses (Simizu 1984). Further investigations into the role of E3 are
hampered by the lack of reagents exclusive to recognizing the E3 glycoprotein.

1.3. Virus Infectious Life Cycle
Reflecting their global presence, these viruses have a broad host range;
additionally, the receptors are not conserved across the various species of
alphaviruses (Helenius 1980; Wang 1992; Byrnes 1998; Klimstra 1998; Heil
2001; Rose 2011). After binding a receptor, clathrin-mediated endocytosis brings
the virus particle into the cell target (Strauss 1994; Bernard 2010). The low pH
environment within the endosome is required to cause the conformational
changes that destabilize the interactions between E1 and E2 (Strauss 1994;
Kolokoltsov 2005; Colpitts 2007). This facilitates disassociation of E2 from E1
and permits the conformational recruitment of E1 monomers into trimers and
position the fusion epitope of each E1 protein in these trimers to fuse with the
endosomal membrane as supported by the pre-fusion and post-fusion structure
determinations for CHIKV at pH 7 and SIND at pH 5.6, respectively (Li 2010;
Voss 2010). The structural proteins of VEEV are targeted for translation from the
subgenomic RNA as a single polyprotein C-pE2-6K-E1 on the membrane of the
endoplasmic reticulum (Figure 3). The capsid protein (C) is translated first and
released by auto-proteolysis leaving a signal sequence at the N-terminus of pE2
that targets the polypeptide for translocation into the endoplasmic reticulum
(Aliperti 1978; Hahn 1990; Strauss 1994).
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Figure 3. Infectious Pathway of Alphaviruses
The infectious pathway of alphaviruses is summarized above. Early steps of
entry include receptor-mediated binding and clathrin-mediated endocytosis by
the E2 glycoprotein leading to a low pH-dependent fusion event by the E1
glycoprotein. Viral replication proceeds following the disassembly of the
nucleocapsid core as the genomic strand is translated to yield the replication
proteins nsP1-4, which facilitate template strand replication among other duties.
As a temporal strategy, structural proteins are translated through a negative
strand intermediate as a single polyprotein. Final maturation steps and assembly
produce virus that exits the cell through budding. Figure taken from Kuhn et al.
(2016).
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Within the lumen of the ER, the proteins are separated by the action of
signal peptidases to form pE2, 6K and E1, and post-translational modifications,
such as glycosylation, occur (Garoff 1974; Raju 1991). The entry proteins pE2
and E1 associate as heterodimers following a translational strategy that retains
pE2 in the ER since it is translated before E1 (Aliperti 1978; Melancon 1987;
Hahn 1990; Kielian 1990; Andersson 2003; Sanz 2002). As the pE2-E1
heterodimer reaches the trans-golgi, pE2 is cleaved by a furin protease into E3
and E2. It is assumed that E3 remains associated with the E2-E1 complex until
the complex leaves the Golgi towards the final assembly of the structural proteins
with capsid protein near the cellular membrane. This association is believed to be
due to the increasingly acidic cellular compartments through which processed
viral glycoproteins transit before assembling at the cell membrane (Strauss 1994;
Paroutis 2004; Uchime 2013; Fields 2015). Mutants with deletions in key tyrosine
residues at the interface of interaction between E2 and E3 or complete
replacement of E3 with a signal-peptide sequence prevents successful transport
of E1 to the cell surface to form mature virions suggesting a critical role of E3
intracellularly in protecting the fusion IJ loop within E1 while associated with E2
before budding from producer cells (Lobigs 1990; Uchime 2013).

1.4. Glycoprotein Transport & Arrangement
The structural components of alphavirus proteins have specific roles
where E2 mediates receptor recognition whereas E1 facilitates membrane class
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II fusion (Strauss 1994; Mukhopadhyay 2006). The E3 glycoprotein, while a part
of pE2, is believed to occlude the fusion peptide region of E1 thus preventing
premature fusion by E1 during transport within the secretory pathway of the
infected cell. The location of E3 KDVEHHQPDSSHGWRWKHȕ-ribbon region
between the A and B domains of E2 in cryo-EM studies (Parades 1998; Wu
2008; Li 2010). This proximity to E2 as a part of pE2 is believed to allow E3 to
form several disulfide bonds with E2 during transport to maintain the stability of
E2 and allow the successful heterodimerization of pE2-E1 (Parrott 2009; Li
2010). Variable cleavage of E3 from pE2 by a furin-like protease in the late
secretory pathway is observed before the virus exits, but the retention of E3 has
been observed structurally for SFV and VEEV. The absence of structural data
showing E3 on other alphavirus members suggests that not all alphavirus
members undergo the same cleavage efficiency or possess different
requirements for pH protection (Lobigs 1990; Jose 2009; Zhang 2011).
Solved structures of SFV E1 in pre-fusion and post-fusion states along
with recent whole-virion cryo-EM structures for SIND, CHIKV and VEEV at high
resolution show that the envelope glycoproteins amongst the various species of
alphaviruses share a common architecture despite differences in the sequence
encoding them (Lescar 2001; Kielian 2006; Roussel 2006; Li 2010; Voss 2010;
Zhang 2011) (Figure 4).
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The dynamic rearrangement of E1-E2 dimers into E1 homotrimers during the
fusion process exposes the hydrophobic fusion peptide region on E1 for insertion
into a host cell endosomal membrane. This allows fusion to occur between the
host cell and viral membranes and permits the delivery of the viral genomic
material into the cytoplasm of the target cell (Hammar 2003; Zaitseva 2005; Liao
2005; Mukhopadhyay 2006; Sanchez-San Martin 2009; Li 2010; Wu 2007)
(Figure 5).
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Figure 5. Class II Fusion of Virus-Host Cell Envelopes
Current model for Class II fusion between two membranes observed in
Alphaviruses and Flaviviruses. A) For Alphaviruses, E2-E1 envelope proteins
present on the surface of the virus (clear membrane) are arranged as trimers of
heterodimers. E2 is colored a light green while E1 is colored according to its
individual domains where blue is DIII, red is DI, and yellow is DII. B) Upon a low
pH event the envelope proteins dissociate and E1 undergoes conformational
changes which extend the monomer towards the target membrane. C) E1
monomers associate into homotrimers while their distal loops containing the
fusion peptide region insert into the target membrane. D) E1 monomers further
undergo conformational changes where DIII folds over the hinge region present
in DI to overlap DII. E) Hemifusion from these conformational changes occurs as
the bridging of these two membranes is carried out through the ³hairpin´ force of
the E1 homotrimers. F) Complete pore formation in which E1 homotrimers have
successfully bridged the viral and target membranes for lipid mixing. The formed
pore now allows the nucleocapsid to enter the target cell cytoplasm. Figure
adapted from Martin et al. (2009).

1.5. Alphaviral Pseudotypes & Design
Vectorology is a branch of virology which involves the manipulation and
construction of viral vectors to deliver payloads to specific cell targets. In

14
principle, this involves utilizing the core of a retrovirus, engineered with an
application in mind, coupled with the envelope of another virus to add specificity.
The range in tropism of retroviral vectors has grown over the years with the
successful creation of vectors expressing envelope glycoproteins with ecotropic,
amphotropic, or pantropic capabilities. (Wool-Lewis 1998; Palu 2000;
Srinivasakumar 2002; Sinn 2003; Simmons 2004; Hafer 2009; Rausalu 2009;
Barrett 2013).
The immunogenicity and cytotoxicity of viral vectors are important factors
to consider when designing and applying pseudotype vectors to cell targets
within a host. These effects are influenced by the expression and association of
protein subunits from different viral sources within a host DQGWKHKRVW¶V
immunologic response (Kahl 2005; Lundstrom 2005). The application for virus
pseudotypes has traditionally been focused with gene therapy in mind, where the
application of viral vectors must be managed against host immune defenses to
avoid complications. However, considerable work has shown that pseudotype
vectors can be utilized to illicit an immune response with the purpose of
vaccination. The application of viral vectors with this goal depends on whether or
not vectors are engineered to allow for replication. Whereas live-attenuated virus
is optimal for establishing immunologic response and prolonged protection,
pseudotype virus and virus-like particles (VLPs) are ill-suited as long-term
solutions with varying levels of success (Akahata 2010; Kramer 2013). However,
replication-incompetent recombinant particles can serve a specialized role in
investigations of protein interactions specifically because they cannot replicate.
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This lack of replication eliminates the portion of the infectious pathway involved in
exit and allows only for the mechanisms of entry to be studied (Sinn 2003;
Simmons 2004; Cho 2008).
The usage of retrovirus-based packaging vectors in the creation of
pseudotype virus is not a new concept and has been successful for decades,
building off the research on murine retroviruses from the late-¶VDQGLQWRWKH
early-¶V. The initial work incorporating the envelope proteins of Vesicular
stomatitis virus (VSV) with Moloney murine leukemia virus (MuLV) and avian
myeloblastosis virus (AMV) capsid cores had introduced the potential for
developing chimeras expressing proteins from separate viruses by altering the
tropism of these viral cores due to the molecular attributes from pseudotyped
envelope proteins (Zavada 1972; Love 1974). The choice of using MuLV is
supported by its ability to incorporate a wide range of heterologous protein
complexes into its capsid, allowing for the potential to create an assortment of
high-titer, retroviral-based pseudotypes (Burns 1993). This success with initial
pseudotypes branched into the usage of lentivirus subtypes and further
expanded both the vector systems available and envelope protein sources to
include filovirus and flavivirus (Wool-Lewis 1998; Bruett 2001; Sinn 2003; Hu
2007). The increasing library of envelope protein candidates from various viral
families grew to include alphaviruses and allowed for the investigation of both
entry mechanisms and the design of therapeutic delivery systems (Sharkey
2001).
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The usage of replication-incompetent, envelope-deficient pseudotyped
virus allows for multiple directions of research from a single approach simply by
altering relatively similar retroviral packaging systems. Through the use of
pseudotype vectors, progress has been made in detecting neutralizing antibodies
to VEEV envelope proteins and in developing gene therapy vectors based on the
tropism of pseudotyped Ebola envelope proteins (Sinn 2003; Kolokoltsov 2006).
Most importantly, the approaches of pseudotype creation have shown that the
processing of chosen envelope proteins and the entry pathways used by them
follow the same criteria seen in the wild-type virus from which they are chosen.
This allows researchers to investigate the properties of the protein interactions
with a cell target and characterize the molecular attributes of specific envelope
proteins (Sharkey 2001; Hu 2007).
The creation of pseudotype virus generally involves the production of a
packaging core capsid that is retroviral in origin from a stably-transfected
producer cell line that has been engineered to be replication-incompetent (Palu
2000). Advances in mammalian packaging systems expressing envelopedeficient, replication-incompetent retrovirus for high-titer chimera production
allow for the substitution of envelope protein candidates to study particular viral
protein interactions on cell targets (Pear 1993; Ory 1996; Swift 2001). These
packaging cells, termed Phoenix System (ࢥNXgp), are modified human
embryonic kidney 293 cells and stably express the sequences encoding the core
retroviral capsid (gag) and polymerase (pol) proteins of MuLV under the control
of the Rous sarcoma virus (RSV) promoter. Stable transfection of these
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packaging cells with a transducible lacZ gene or fluorescent reporter allows for
assaying successful entry following the transient transfection of a helper plasmid
containing the sequence that encodes the envelope protein of a chosen virus
including alphaviruses under the control of the cytomegalovirus promoter (CMV)
for high-level mammalian expression (Figure 6).

Figure 6. Mammalian Expression of Pseudotype Virus Using the Phoenix System
PhoenixGP cells are altered human kidney 293T cells engineered to express the
gag and pol genes from Moloney murine leukemia virus lacking the LTR regions
DQGȥVLJQDOVHTXHQFH7KHVHFHOOVSURGXFH replication-incompetent, envelopedeficient MuLV particles. Stable transfection with MFG.nls.LacZ, a recombinant
retroviral genome containing the gene that encodes ȕ-galactosidase flanked by
LTR regions and possessing a ȥVLJQDOVHTXHQFHIRULQFRUSRUDWLRQDOORZVIRUWKH
transduction of a reporter gene into target cells that can be assayed with the
addition of X-gal. The transient expression of a helper plasmid containing the
chosen envelope protein (e.g. VEEV) produces retroviral pseudotypes with
alphaviral envelope proteins that dictate the tropism of the pseudotyped viruses
based on the interactions of the viral envelope proteins and receptors/attachment
factors on target cells.
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The creation of pseudotyped virus from insect cells follows a similar
approach. However, there are limits to expressing viral proteins within insect
cells due to the failure of RSV/CMV promoters being compatible with insect
producer-cell transcription machinery. Expression of viral pseudotypes in insect
cells utilizes a different expression system designed around insect cell-derived
polyhedrin promoters using a baculovirus core capsid (Liu 2013). Baculovirus
engineered to lack the native envelope glycoprotein (gp64) is rendered
replication-incompetent (Tani 2001; Kitagawa 2004). These gp64-null core
constructs can be further engineered with a sequence encoding the green
reporter protein fluorescent signal (GFP) from Aequorea Victoria (Kitagawa
2005). Baculovirus cores can then be co-transfected with helper plasmids
containing sequences encoding foreign viral envelope proteins under the control
of a late-stage polyhedrin promoter into producer Sf9 cells to create pseudotype
baculovirus that is replication-incompetent and bearing foreign envelope proteins
(Westenberg 2012). These pseudotyping techniques provide a unique
opportunity to study the interactions between the pseudotyped viral envelope
proteins and their receptors on the cell surface of targets. These interactions
must take place in order for transduction of a reporter gene to occur, while
avoiding in vitro culturing artifacts that can arise from serial passaging virus in
different cell types.
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CHAPTER 2. MATERIALS & METHODS

2.1. Cell Lines & Cell Culturing
HEK293T-EDVHGĭ1;JS 3KRHQL[ CRL-3215) producer mammalian cells
were obtained from the American Type Culture Collection (ATCC) in Rockville,
MD. These cells are engineered for the stable expression of replicationincompetent, envelope-deficient MuLV core proteins (Pear 1993; Swift 2001).
Baby hamster kidney epithelial cells (BHK, CCL-10 ± ATCC) were the
mammalian target cells for all assays. Sf9 insect cells used for both insect cell
virus production and cell targeting were graciously donated by Andy Mesecar
(Purdue University, West Lafayette, IN.). CHO 22/18.4 mammalian cells that
express HS or are engineered to lack HS at the cell surface, respectively, were
graciously donated by Richard Kuhn (Purdue University, West Lafayette, IN.).
All mammalian cells were incubated at 37°C with 5% CO2
supplementation in DMEM media (Gibco ± Invitrogen) supplemented with 10%
heat-inactivated FBS. All insect cells were incubated at 28°C with no CO2 in
Sf900III media (Gibco ± Invitrogen) supplemented with 3% heat-inactivated FBS.
No antibiotics were used in cell culturing. Mammalian cell passaging was

20
performed every 2 days and required washing cells with 1% PBS and treatment
with 0.25% Trypsin/EDTA for 1 minute before suspending cells into solution with
fresh DMEM/10% FBS media for splitting. Moderately adherent Sf9 cells were
passaged every 3 days by removing old media and replacing with fresh
Sf900III/3% FBS media and shaking the monolayer into suspension for splitting.
All culturing was performed in flasks treated with poly-L-lysine for cell attachment
(Sarstedt).

2.2. Alphavirus Production Plasmids
3URGXFHUĭ1;JSFHOOVZHUHVWDEO\WUDQVIHFWHGZLWKS-SXURDQG0)*6nlslacZ to select for retroviral packaging-producer cells expressing the nuclearlocalized lacZ JHQH ĭ1;JS/DF=). This gene is used in assays of infected target
cells for the H[SUHVVLRQRIȕ-galactosidase following transduction (Morgenstern
1990; Ory 1996). Mammalian expression of the VEEV alphavirus envelope
proteins of the wild type TC-83 strain or a mutant sequence with a R58-59E
deletion in the furin cleavage motif in E3 was performed using the pcDNA3.1
vector plasmid with the sequence encoding E3-E2-6K-E1 polyprotein under the
CMV promoter. Expression of the VEEV envelope proteins in insect cells was
achieved by subcloning the sequence encoding the wild type and mutant R5859E E3-E2-6K-E1 polyprotein into the insect cell helper plasmid vector pBACgus1 under control of a polyhedrin promoter (Novagen). Gene sequences were
digested from pCDNA3.1 using HindIII and XbaI. The pBACgus-1 vector was
digested with HindIII and AvrII for a complementary end ligation using T4 Ligase
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to create pBACgusVEEV and pBACgus58-59 for the wild-type and mutant
sequence, respectively (New England Biolabs ± NEB). Sequences underwent
diagnostic digestion with EspI for validation before sequencing.

2.3. Transduction Assay
Pseudotyped virus produced from either mammalian or insect cells under
standard conditions of pH or adjusted pH was collected from the supernatant
media of cultured cells and filtered through a 0.45 µM membrane to remove cell
debris. Virus was either concentrated from media with ultracentrifugation through
a 5 mL 30% sucrose cushion at 28,000 RPM @ 4°C for 2 hours or directly
applied onto target cells with 5 ug/mL polybrene (Sigma-Aldrich) for 3 hours
before being removed and replaced with fresh media. Pseudotyped virus binds
and enters cell targets dependent on the protein interactions mediated by the
viral envelope glycoproteins. Entry allows the transduction of the reporter gene
DQGVXEVHTXHQWȕ-galactosidase activity for assaying in mammalian cells after 48
hours. The observation of GFP fluorescence was performed after 72 hours in
insect cells.
Traditional multiplicity of infection (MOIs) or plaque assays cannot be
performed with replication-incompetent virus. Virus titer quantities are directly
assayed from transduced reporter signal RIȕ-galactosidase activity (mammalian
cell infection) using 5-bromo-4-chloro-3-indolyl-ȕ-D-galactopyranoside (X-gal,
Gold Bio) or GFP (insect cell infection) fluorescence detection under the
microscope. Depending on the amount of supernatant media applied to target
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cells for infection and the percentage of cells expressing the reporter from the
total amount of cells plated, the transducing units per milliliter (TU/mL) of media
can be computed to yield the virus titer from the producer cell source that was
transiently transfected to express pseudotyped virus.

2.4. SDS-PAGE Immunoblot Assay
Virus was produced from twelve, 10-cm plates each containing 8x106
ĭ1;JSFHOOVthat were transfected with a pcDNA3.1 mammalian expression
vector carrying the sequence coding for the structural proteins E3-E2-6K-E1 of
VEEV under the CMV promoter and incubated at 37°C with 5% CO2 (Fig. 6). The
cell cultures had their pH adjusted to 6.5 with 50 mM MES buffer in fresh DMEM
media 44 hours later. Virus was collected after 48 hours and filtered through a
0.45 µM membrane. The sample was divided and pH adjusted to 7.4 or 6.1 using
pre-titrated volumes of 50 mM NaOH or 50 mM MES before being concentrated
through a 30% sucrose buffer adjusted to pH 7.4 (50 mM HEPES, 100 mM NaCl,
and 1.8 mM CaCl2) or pH 6.1 (25 mM HEPES, 100 mM NaCl, 1.8 mM CaCl2, and
25 mM MES) at 4°C for 2 hours at 28,000 rpm.
The isolated pellets were recovered in 2x loading buffer and separated
through 12.5% SDS-PAGE gel electrophoresis. The samples were transferred
onto a 0.45 µM nitrocellulose membrane and blocked with a 5% bovine albumin
washing buffer for 30 mins before being probed for 24 hours at 4°C with primary
rabbit-S$EĮ9((9(DWFRQFHQWUDWLRQ7KHPHPEUDQHZDVZDVKHG[
ZLWKZDVKLQJEXIIHUDQGWKHQSUREHGZLWKVHFRQGDU\JRDWĮ5DEELW-pAb
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conjugated to HRP at 1:2,500 concentration for 4 hours at 25°C. The membrane
was washed again 2x with washing buffer before development solution was
applied.

2.5. Neutralization Assay
Antibody neutralization experiments were performed with virus produced
from six, 10-cm plates each containing 8x106 ĭ1;JS cells as previously
described. Adjustments in pH of virus cultures to 6.5 were performed using pretitrated volumes of 50 mM MES 44 hrs following transfection. Virus was collected
4 hrs later and filtered through a 0.45 µm membrane. The sample was divided,
and the pH was adjusted to 7.4 or 6.1 using pre-titrated volumes of 50 mM NaOH
or 50 mM MES, respectively. Samples were then concentrated as previously
described before being recovered in 6ml DMEM/10% FBS media adjusted to pH
7.4 or pH 6.1 and divided into 1 ml aliquots. Aliquots were incubated with a
rabbit-S$EDQWLERG\Į9((9(DWDQGFRQFHQWUDWLRQVRUUDEELWVHUXP
at 1:50 concentration for 1 hr at 25°C. Hexadimethrine bromide (Polybrene ±
Sigma) was added to each sample at a final concentration of 5 µg/ml before
being applied to target BHK cells for 4 hrs at 37°C. Samples were then aspirated
DQGIUHVK'0(0)%6PHGLDZDVDSSOLHG7KHWUDQVGXFWLRQRIDȕgalactosidase reporter gene was assayed using X-gal 48 hrs later.
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2.6. Indirect-Immunofluorescence Assay
ĭ1;JSFHOOVWKDWZHUHWUDQVIHFWHGDQGH[SUHVVLQJYLUXVKDGWKHLUFXOWXUH
pH adjusted for 4 hrs before being fixed. Fixation methods were performed with
membrane permeating 100% methanol or 4% paraformaldehyde/0.1%
glutaraldehyde with or without triton X-100 treatment to compare extracellular
and intracellular E3. Primary rabbit-S$EĮ9((9(ZDVDGGHGIRUKU#57
6DPSOHVZHUHWKHQZDVKHGDQGSUREHGZLWKDVHFRQGDU\Į5DEELWDQWLERG\
conjugated to Alexa488 (Parker 2010). All samples were treated with Hoechst
33342 stain. Qualitative results using multi-wavelength, inverted fluorescent
microscopy (Olympus IX 81 with MetaMorph v7.6) were performed to support the
data from western blot and neutralization studies. Quantitative observations
using the corrected total cell fluorescence across triplicate assays were
calculated using ImageJ processing software (NIH) to account for variance in
fluorescence brought on through membrane permeabilization.

2.7. Heparan Sulfate Binding Assay
Two cell lines, CHO 22 and CHO 18.4, were used to test the importance
of HS presence to E3 presentation on mature VEEV virus. CHO 22 expresses
HS at the cell surface however CHO 18.4 does not. CHO 22 and CHO 18.4 cells
were each plated into separate 6-well plates at 5x105 cells per well with
DMEM/10%FBS media. Prior to incubation with virus, 3 wells were treated with
6ug/ml heparinase I (Sigma-Aldrich) for 1 hour at room temperature while 3 wells
were left untreated. Virus was produced as previously described using the
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Phoenix system in environmental conditions of pH 7.4 or pH 6.1, concentrated
through a pH-adjusted 30% sucrose cushion at 28,000 RPM for 2 hours and
applied to target CHO 22 or CHO 18.4 cell sets in triplicate for both sets. Virus
was removed after 3 hours and replaced with fresh DMEM/10%FBS media and
incubated at 37°C with 5% CO2. Transduction was assayed after 48 hours.

2.8. NRAMP Transduction Assay
Cells were passaged in separate T25 flasks and were treated with 160µM
exogenous ammonium iron citrate III (Sigma-Aldrich) for 72 hours or standard
DMEM/10% FBS media as a control. 24 hours prior to applying virus, all cells
were treated with 0.25% trypsin and plated in 6-well plates to produce 3 sets of
triplicate wells for samples. Cells treated with 160µM exogenous ammonium iron
citrate ,,,ZHUHODEHOHG³KRXUV´DQGFHOOVWUHDWHGZLWKVWDQGDUGDMEM/10%
FBS media were labeled ³24 hours´ or ³1R,URQ&RQWURO´ 7KHFHOOVODEHOHG³
KRXUV´WKHQKDGWKHLUPHGLDVXSSOHPHQWHGZLth 160µM final concentration
ammonium iron citrate. Cells had virus applied the next day with supplementation
of 160µM final concentration ammonium iron citrate for 3 hours after which media
was removed and replaced with fresh DMEM/10% FBS media. After 48 hours, for
all labeled samples, one set was assayed for transduction of the reporter gene.
The second set was fixed in 4% paraformaldehyde/0.1% glutaraldehyde while
the third set had the cells removed to undergo lysis for immunoblots to assay
intracellular production of NRAMP. The second set of fixed cells were probed
with primary rabbit-Į15$03DWLQ[3%6%6$IRUKRXUVEHIRUHEHLQJ
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washed and probed with secondary goat anti-rabbit IgG-Alexa488 at 1:200 for 1
hour. The supernatant extracts from cells from the third set that underwent lysis
had 2x laemmli buffer added at 1:1 v/v ratio and used in 12.5% SDS-PAGE
before being transferred to a 0.45µM membrane that was probed with primary
rabbit-Į15$03DWIRUKRXUVZDVKHGDQGWKHQSUobed with secondary
anti-rabbit IgG HRP at 1:1,000 for 1 hour before being developed and imaged.
These sets allowed for direct comparison of virus entry to intracellular and cellsurface levels of NRAMP.
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CHAPTER 3. INVESTIGATING THE ROLE OF THE ALPHAVIRAL E3
GLYCOPROTEIN IN LOW pH

3.1. Abstract
Despite the growing evidence supporting a crucial role for E3 association
during intracellular transport, direct evidence of E3 glycoprotein still attached to
budding virus without the use of mutants in any species of the alphavirus genus
UHPDLQVHOXVLYH 3DUNHU6MऺEHUJ=KDQJ8FKLPH 7KH
pseudotyping of viral constructs was performed to produce virus to investigate
the retention of E3 on mature virus particles. Expression of VEEV envelope
proteins with mammalian MuLV packaging vectors that are envelope-deficient
and replication incompetent permits the ability to safely work with a BSL3 agent
in a BSL2 environment. Furthermore, mutations in strains corresponding to in
vitro cell passage adaption in replicating virus do not effectively exist as artifacts
here, allowing this system to observe the chemistry of envelope proteins without
selection (Bernard 2000; Smit 2002).
Production and retention of E3 protein at low pH was assayed directly in
immunoblots and using immuno-fluorescence microscopy (IFA) using a
polyclonal
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antibody specific to VEEV E3 generated in the lab. Indirect analysis of E3 was
carried out in antibody neutralization studies. Since plaque assays cannot be
performed on replication-incompetent virus, transduction assays served in
TXDQWLI\LQJYLUXVWKURXJKYLUDOHQWU\DQGDVXFFHVVIXOO\WUDQVGXFHGȕgalactosidase gene. The data strongly supports that E3 is retained at low pH and
absent at higher, physiological pH levels on mature virus outside of the cell. This
retention is present on both virus particles as well as on the cellular surface of
producer cells.

3.2. Introduction
In alphaviruses the translation of the E2 and E3 envelope glycoproteins
occurs as the polyprotein precursor pE2. While the roles of E2 and E1 have been
studied and well characterized over the years, the role of E3 has only been
recently observed as crucial in the success of infectious mature virus particles
(Lobigs 1990; Uchime 2013; Fields 2015). The E3 glycoprotein is a small,
cysteine-rich 7kD protein present in all the alphaviral species members with
approximately 50% sequence similarity between them. It remains a part of pE2
until a late-stage cleavage event by a cellular subtilisin-like furin protease
between the trans-golgi and cell surface (Nakayama 1997). It is believed that
XSRQFOHDYDJHDWWKHIXULQPRWLIWKHȕ-ribbon linker between domains A and B of
E2 is destabilized, priming the spike for low pH activation and subsequent
disassociation of E2 from E1 to permit the conformational changes necessary for
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fusion within the endosome (Jose 2009; Li 2010; Voss 2010). The association of
the E3 glycoprotein, including after cleavage, is exclusively with that of the E2
glycoprotein. This association with E2 protects the E1 fusion motif through highly
conserved residues and intracellular, pH-dependent electrostatic associations
(Zhang 2011; Uchime 2013; Zeng 2015). For many years this E3-E2 association
was assumed to disassociate with E3 lost to the extracellular environment after
leaving the mature spike complex of E2-E1. With increasing data supporting an
intracellular role in stabilizing E2 and protecting E1 from premature fusion during
transport, it is possible that this role of E3 can extend to that of mature virus
outside the cell.
Alphaviruses have a temporal strategy for the processing of structural
proteins to ensure successful transport within a cell before assembly. The pE2
protein sequence is translated first and is retained through lectin-mediated
chaperones to form heterodimers with E1 proteins translated thereafter within the
endoplasmic reticulum (Andersson 2003). However, in low pH, the association of
E3 with the E2-E1 heterodimer as a part of pE2 is crucial to protect against
premature fusion and maintain stability of the spike complex. The requirement for
protection helps explain the late-stage intracellular cleavage of pE2. Following
cleavage, however late, E3 is subject to retention due to compartmental pH
levels while within cell. This suggests that the association of E3 must be able to
accommodate a variable level of pH throughout the infectious pathway including
that of the environment the virus is budding into (Kim 1998).
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The appearance of E3 on the mature particle is limited to structural
evidence for SFV and a best-fit model predicting its association with E2 for
VEEV, supported by cleavage mutants and cell-based studies involving SIND
DQG6)9PXWDQWV /HVFDU6MऺEHUJ=hang 2011). However, it is
unclear as to the extent or the mechanism that the appearance of E3 on mature
virus is observed with SFV or if the appearance of E3 on mature virus could
include other alphavirus members (Paredes 1998; Lescar 2001). Given the
variance in sequence similarity and cellular tropisms across the various species
of alphaviruses, properties affecting the processing and retention of the E3
glycoprotein need to be considered.
Direct evidence of VEEV E3 on mature virus has remained elusive given
its inherent size and orientation on the spike complex of virions. The only
published data showing the E3 glycoprotein along with the other structural
envelope proteins, E2 and E1, came from using overexpressed viral protein from
bacterial cells to determine the structure of the spike complex of VEEV at 4.4
angstroms resolution. This required large amounts of culture followed by an
intensive purification protocol and shown unmodified viral E3 protein (Zhang
2011). Currently, there has been no work observing expressed E3 glycoprotein
from virus-producing cells. Strain-specific neutralization of VEEV using generated
monoclonal antibodies against E3 has been observed suggesting E3 was
present on mature virus, but the same study was unable to successfully show
recognized E3 on immunoblots or through indirect-immunofluorescence assays
with the same antibodies (Parker 2010). Less than a year later, it was observed
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that the E3 glycoprotein could remain associated with the E2-E1 heterodimer
spike following cleavage in acidic compartments within infected cells using
PXWDQWVIRU6)9 6MऺEHUJ Consideration of these findings suggests VEEV
expresses E3 on mature virus particles and a potential pH-dependent retention
mechanism exists that could be occurring with VEEV E3 and shared across other
species of alphavirus.
In order to investigate whether the E3 glycoprotein can be retained on
mature virus in a pH-dependent manner, we utilized the Phoenix mammalian
expression system to produce non-replicative virus that avoids culturing
adaptions. Adaptive mutations in viral studies have played a large role in
revealing critical residues responsible for infectious roles. A considerable amount
of epidemiological research has focused on the various species members and
their variants that demonstrate an increased virulence or tropism range.
Serological isolates recovered from outbreaks and individual cases for CHIKV
has shown that a key A226V amino acid substitution in the E2 glycoprotein
allows virus to bypass the cholesterol requirement considered crucial to
alphavirus entry (Strauss 1994; Chatterjee 2000; Lu 1999; Tsetsarkin 2007). This
capacity for virus to mutate in vivo has been studied in vitro for prototypic
members SIND and SFV in the cell passaging of wild-type strains AR339/SFV4
to map key nucleic-acid mutations and amino-acid-residue changes that confer
increased virulence, expanded tropism, or rescued infectivity of the species in
novel mutants (Klimstra 1998, 1999; Smit 2002; Ryman 2007; Knight 2009). This
in vitro approach was also applied to structural studies for SFV to map
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conformational changes necessary for fusion by E1 (Tubulekas 1998; Liao 2005;
Liu 2009). The caveat to these studies is that in vitro replicating virus can evolve
into a product of the experimental conditions that it is being studied, and these
artifacts should be considered when making predictions and applying findings to
in vivo behaviors outside the laboratory setting (Klimstra 1998; Smit 2002; Hafer
2009). Ultimately, the specialized design and non-replicating nature of
pseudotype virus creation is the best approach to investigate virus and host cell
protein interactions without adaption and cultural artifacts affecting nucleotide
sequences.
In order to probe for and determine the location of the E3 glycoprotein, our
lab had successfully generated from rabbits one of the first polyclonal antibodies
specifically against the E3 glycoprotein for alphaviruses using a novel expression
method for purified VEEV E3. Characterization of the antibodies showed that
recognition was species specific, VEEV pE2 from virus-producing cell lysate and
overexpressed E3 protein from bacterial cells was recognized in immunoblots
whereas RRV or CHIKV pE2 and E3 were not (Laura Hughes-Baker thesis
work). We attempted to investigate if E3 was retained in a pH-dependent manner
using these polyclonal antibodies in efforts to explain the protection from VEEV
of mice immunized with monoclonal antibodies against E3 using the capability of
E3 to bind the spike complex at low pH. Determining the fate of the E3
glycoprotein following cleavage could help clarify whether protection in mice was
coming from antibody recognition of pE2 or retained E3.
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3.3. Results
3.3.1. Production of VEE Pseudotype Virus Retaining E3
Immunoblot analysis was performed utilizing polyclonal antibodies to
visualize expressed E3 directly from virus-producing cells using virus budding
from twelve, 10-cm plates each containing 8x106 ĭ1;JSFHOOV 3KRHQL[± ATCC)
that were transfected with a pcDNA3.1 mammalian expression vector carrying
the sequence coding for the structural proteins E3-E2-6K-E1 of VEEV. Samples
were adjusted to either pH 6.1 or 7.4 using 50mM MES or NaOH, respectively.
For virus produced at pH 7.4, it was observed that E3 was not retained on
budded mature virus, whereas for virus produced at pH 6.1, it was observed that
E3 was retained on budded mature virus. There was comparable expression of
pE2 and E1 envelope protein between samples at both pH 7.4 and 6.1 in
immunoblots (Figure 7).
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3.3.2. pH-Dependent Neutralization of VEEV Using E3 Polyclonal Antibodies
It is hypothesized that virus treated with an antibody against E3 will
significantly diminish the transduction efficiency of virus budding off into an
environment with lower pH and retaining E3 through an electrostatic association
with E2. Antibody neutralization experiments were performed in separate pH
conditions of 7.4 and 6.1 seen in immunoblots as influencing the retention of E3
on budded VEEV pseudotyped virus. Initial neutralization of pseudotype virus
prepared at pH 7.4 or 6.1 was performed using an increasing concentration of
polyclonal antibodies against E3. Transduction efficiency was measured in
transducing units per milliliter of applied media (TU/ml). There was significant
neutralization of VEEV expressed at pH 6.1 that was absent in virus expressed at
pH 7.4. The difference in pH between pseudotype virus samples did not cause
any significant reduction of transduction. The neutralization increased with the
concentration of antibody for virus samples expressed at pH 6.1 with no
observable decrease in transduction efficiency by virus treated with rabbit serum
only (Figure 8).
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concentration in samples treated at low pH 6.1 that is absent at higher pH 7.4
levels. Rabbit serum was used at a concentration of 1:50 of total buffer volume
for samples expressed at pH 7.4 and pH 6.1 to observe any difference in virus
production brought on by the serum itself. Transduction efficiencies of
pseudotype virus, like the preliminary assays, show no significant difference
between viruses prepared at either pH. These data support the hypothesis that
virus budding off into low pH can be neutralized by antibodies against the E3
glycoprotein, and the absence of neutralization at pH 7.4 supports the observed
pH-dependent retention of E3 on mature virus seen in immunoblots (Figure 9).
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as cleaved E3, ĭ1;JScells transfected with the wild-type sequence encoding
the envelope proteins for TC-83 VEEV to express VEEV enveloped MuLV
pseudotype virus (WT) were fixed with formaldehyde and permeated or not
permeated to observe cell surface versus intracellular E3 following probing with
S$EĮ9((9(In producer cells fixed with formaldehyde, the cell-surface
localization of extracellular E3 is significantly higher in fixed but not
permeabilized cells that have been incubating in media at pH 6.1 (Figure 10A)
than it is in cells that had been incubated at pH 7.4 (Figure 10B). Once treated
with the permeating agent Triton X-100, there is an increase of E3 signal for both
pH samples as intracellular pE2 and cleaved E3 are labeled (Figure 10C & D).
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3.4. Discussion
The retention of the E3 glycoprotein on budded, mature virus in a pHdependent manner was investigated using a species-specific polyclonal antibody
against VEEV E3. The media of producer cells budding pseudotype VEEV was
adjusted in pH to investigate if a low extracellular pH would promote the retention
of the E3 glycoprotein on the envelope spike following furin cleavage.
Immunoblots show the presence of E3 in virus samples prepared from cells
adjusted to pH 6.1 that is absent in virus samples prepared for cells at pH 7.4.
We also show the presence of the E3 glycoprotein in expressed virions. In
neutralization assays, there was a significant decrease in transduction of the lacZ
reporter gene resulting from entry by VEEV pseudotype virus produced at pH 6.1
in the presence of polyclonal antibodies against E3 that was absent for the same
virus prepared at pH 7.4. This neutralization increased with antibody
concentration and was not affected by the difference in pH. Overall transduction
levels of virus exiting at pH 6.1 were lower, but this is not statistically significant.
This could be due to a few possibilities. First, the percentage of virus budding
and retaining E3, even transiently, could be noninfectious due to the structural
hindrance the presence of E3 still associated with the E2-E1 heterodimer spike
could pose on receptor binding and conformational changes. Second, a
percentage of virus budding with retained E3 could potentially be binding
something at the producer cell surface and fail to successfully disassociate from
the producing cell.
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In the immunofluorescent microscopy studies, the location of E3 was
investigated in virus-producing cells at pH 7.4 vs pH 6.1. The presence of
intracellular E3, as a part of pE2 or cleaved, was compared to cell-surface levels
of E3 of producer cells in pH 7.4 vs pH 6.1 both qualitatively and quantitatively.
The fluorescence signal represents the amount of E3 glycoprotein retained on
mature virus and shows a qualitative increase on fixed producer cell samples at
pH 6.1 compared to fixed cells at pH 7.4. This increase is statistically significant
between the differences in pH when comparing the averaged total cell
fluorescence of each well in triplicate assays. In fixed producer cells that have
been treated to permeate the cellular membrane, total E3 signal is comparable
across all producer cell sets independent of fixation method. This is due to
intracellular E3 being accessible and recognized by antibody, thus raising the
overall signal of pH 7.4 samples comparable to pH 6.1 samples and suggesting
intracellular production of virus proteins is not affected by the changes in pH
outside the producing cell.
Interestingly, the use of a furin cleavage mutant (R58-59E) that covalently
retains E3 as part of the envelope spike on budding VEEV pseudotypes showed
an increase of E3 fluorescence at pH 6.1 compared to pH 7.4 from cells fixed
with 4% formaldehyde that were not permeated. It is not clear why this is,
however, large deviations for those samples budding virus with the R58-59E
substitution can be seen for both formaldehyde and methanol fixation methods.
This range of variation could possibly be due to differences in production of the
mutant particles versus virus containing the wild type sequence for furin
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cleavage. However, once permeated with triton X-100, the intensity of E3 signal
is more comparable between pH 6.1 and 7.4 once intracellular E3 is recognized
by antibody. This suggests the differences of signal between pH 6.1 and pH 7.4
for furin cleavage mutants could be stemming from differences in virus assembly
and exit and not from levels of protein production. The difference in signal
intensity for R58-59E between the two pH levels is not seen in cells fixed in
methanol. Furthermore, the signal for cells budding virus with the wild-type
sequence for furin cleavage at pH 6.1 before being fixed with methanol is greater
than those cells at pH 7.4 before fixation. While this level of signal between these
comparisons is not equal despite intracellular production of E3 being accessible
to antibody, fixation with methanol can remove a considerable amount of protein
at the cell surface, including E3, and potentially explain the differences between
signals.
The presence of the E3 glycoprotein on mature virus introduces another
DVSHFWRIWKHSURWHLQ¶VUROHIROORZLQJYLUXVSURFHVVLQJDQGEXGGLQJfrom infected
cells. The crystal structure for the entire glycoprotein spike has been solved at
physiological pH and low pH for CHIKV and SIND, respectively, showing E3
associating exclusively with E2. This is supported by the cryo-EM structure of the
entire VEEV virion at 4.4Å and in mutagenesis studies of key residues between
E2 and E3 in VEEV and cleavage-impaired SIND and SFV mutants (Parades
1998; Li 2010; Voss 2010; Zhang 2011; Uchime 2013). As a member of the
alphavirus genera with over 26 separate species, it is likely that after leaving the
cell, VEEV has adapted the ability to protect the fusion epitope of E1 while
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budding into acidic environments. As virus exits cells in environments where cells
are potentially undergoing apoptosis or necrosis, the same mechanism by which
E3 prevents premature fusion by E1 during intracellular transport would be
required to prolong protection to that of the varying degrees of pH outside a
budding cell. This capability to extend the association of E3 to the E2
glycoprotein, probably through an electrostatic association in the presence of
abundant protons from low pH, can also explain how antibody neutralization is
possible of virus retaining E3 on its surface. Indeed, the structural data for VEEV
E3 shows that it is favorably positioned distal to the viral membrane associating
with E2 and likely to participate in binding if present. Given binding associations
with such motifs like heparan sulfate have already been identified for
alphaviruses and in lab adapted strains of the E2 glycoprotein, the retention of
E3 adds another potential site for protein interactions.
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CHAPTER 4. CHARACTERIZING THE EFFECTS OF E3 GLYCOPROTEIN
RETENTION ON CELLULAR TROPISM & ENTRY

4.1. Abstract
The transient retention of the E3 glycoprotein on mature virus particles
offers a new avenue for protein interactions between virus and extracellular
proteins. It has been observed that the furin cleavage motif between E3 and E2
binds to heparan sulfate (HS) in lab-adapted strains of SIND and cleavage
mutants presenting E3 as a part of pE2 for SFV. This increased binding capacity
is believed to be due to the similarities in the residues known to participate in
binding one of the four known sequences of HS binding (XBBXBX) and those in
pE2 recognized by the subtilisin-like furin protease (XBXBBX) where X,
hydrophobic residue; B, basic residue (Klimstra 1998, 1999; Zhu 2010). It has
also been observed that the natural resistance-associated macrophage protein
(NRAMP) is a definitive receptor of the prototypic alphavirus member SIND
(Rose 2011). This receptor was targeted for downregulation in its cell surface
expression using exogenous iron supplementation to probe the impacts of pHdependent, transiently-associated E3 on virus entry. Our data show a significant
decrease in entry and reporter gene transduction by VEEV pseudotype virus
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following the downregulation of NRAMP expression for BHK cell targets. This
decrease is absent in RRV pseudotype controls. This suggests that VEEV
utilizes NRAMP as a receptor. We also found for VEEV pseudotypes retaining E3
at low pH an ability to bind HS as an attachment factor which rescues infection
and results in a significant increase in entry and gene reporter transduction in
BHK cells lacking NRAMP on the cell surface. Taken together, these findings
suggest that the ability to bind HS as an attachment moiety by E3 on mature
virus impacts the tropism and entry of particles, permitting the virus to bypass the
negative effects of NRAMP receptor downregulation.

4.2. Introduction
The processing of pE2 has been observed to vary across cell types
budding mature virus. A percentage of particles do retain pE2 on the virus coat,
which has been shown to inhibit infectivity despite not being disruptive of the
assembly and budding processes (Zhang 2002). The importance of pE2
cleavage is supported by work with mutant CHO-K1 cell lines protected from
SIND infection due to a cleavage-deficiency for pE2 by a lack of furin protease.
Indeed, cell-dependent infection requires successful processing of pE2 across
mammalian cells with a stricter requirement in insect cells (Watson 1991;
Heidner 1996). Mutants in which E3 is covalently associated to E2, show
significant attenuation of entry by VEEV and SFV particles due to E3 blocking
spike activation 6ZDSQD$SWHWKHVLVZRUN6MऺEHUJ The contacts made by
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(WRWKHȕ-ribbon region of E2 are disordered after cleavage priming E3 for
disassociation following a low pH trigger. This permits the conformational
changes within the E2 linker region for proper disassociation of E2 from E1 to
allow orientation of the E1 trimer assembly necessary for fusion (Li 2010; Voss
2010). In order for a mature virus particle to be optimally infectious, E3 must be
removed from E2 on the virus at basic pH in order to permit the conformational
changes necessary for E1 to initialize fusion. Covalently associated E3 prevents
these structural changes, whereas cleaved E3 does not.
Despite the presence of E3 glycoproteins on mature particles, production
and release of virus is not inhibited (Tubulekas 1998). Work with SFV cleavage
mutants retaining E3 on budded, mature virus suggested a low-pH requirement
for its retention outside the cell. However, a similar low-pH environment exists
within the cell during transport and assembly of the virus structural proteins. It is
unclear how much of the virus retains the E3 glycoprotein for the protection of the
E1 fusion peptide region when the association of E3 with the spike complex
outside the cell is detrimental to infectivity 6MऺEHUJ . The successful
neutralization of wild-type TC-83 strain VEEV virus with monoclonal antibodies
against E3 following challenge in mice suggests that budding virus retains
enough E3 glycoprotein to be significantly inhibited (Parker 2010). Furthermore,
the furin cleavage site within pE2 allows for the retention of the furin motif
sequence on E3 which itself is suggested to be topologically positioned and
favorable for binding interactions (Klimstra 1998, 1999; Parker 2010; Zhang
2011; Uchime 2013). Transiently associated E3 in low pH environments outside
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the cell could potentially explain these observations and offer new binding
capabilities to mature virus.
Our previous findings suggest a pH-dependent mechanism that could
explain how a transient association of E3 with the E2-E1 spike would be
possible, as E3 would continue its protective role through electrostatic
association. Knowing this, we investigated what potential purpose would exist
that would select for virus retaining an otherwise detrimental protein association
outside the cell. Since no known receptors that bind the E2 glycoprotein have
been shown to interact with E3 directly, an ancillary role for transientlyassociated E3 in binding attachment factors is possible (Wang 1992; Linn 2005;
Kielian 2010; Rose 2011). Of the identified cell-surface moieties known to
facilitate virus attachment, heparan sulfate (HS) has been implicated before in
virus binding by the E2 glycoprotein in RRV and SIND through cell passage
studies and investigations of binding sites on E2 using Cryo-EM (Heil 2001;
Zhang 2004; Zhu 2010). Tissue culture adapted strains of VEEV have been
shown to be capable of binding HS from mutations within E2 to positively
charged amino acids. This ability to bind HS decreased entry for VEEV in CHO
cell lines lacking cell surface HS (Bernard 2002).
Heparan sulfate is a ubiquitous glycosaminoglycan (GAG) moiety with
sulfonated disaccharide chains present on most cell types that permits an
electrostatic association with oppositely charged residue side-chains of proteins.
Its role in biological processes includes angiogenesis, blood coagulation, and in
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negative regulation of cell-cell attachment 2¶'RQQHOO0HQHJKHWWL 
HS has been implicated as an attachment factor for various viruses besides
alphaviruses over the years. Binding studies with respiratory syncytia virus and
with the flavivirus Dengue (DENV) have shown virus capable of utilizing HS to
enter cell targets (Hallak 2000; Dalrymple 2011). Cell culture adaption and work
with mosquito salivary glands have also shown HS to possess the capacity to
bind strain-specific SIND isolates (Ciano 2014). This capacity of binding HS
moieties appears only limited to the ability of the virus to acquire adaptive
mutations to charge-favorable residues. Indeed, studies with point mutations on
the E2 glycoprotein of SIND, CHIKV, and SFV have all shown changes in
virulence based on the acquired attachment to HS moieties (Bernard 2000; Heil
2001; Smit 2002; Gardner 2013, 2014).
The only evidence suggesting E3 on mature virions comes from structural
studies on SFV, which also has been shown to bind HS (Lescar 2001; Smit
2002). The similarities between the furin-like protease cleavage motif and the
residues observed capable of binding cell surface HS offer an opportunity to
investigate the impacts of transient E3 retention on viral entry as it can potentially
serve in binding an attachment factor and impact virus infectivity (Klimstra 1998,
1999). Indeed, with lab-adapted strains and natural variants, it was shown that
association with attachment factors could guide the receptor interaction and
tropism of alphavirus members. Work with North American eastern equine
encephalitis virus (NA-EEV), Eastern equine encephalitis (EEEV), and SIND
have shown that these specific alphavirus species can use E2 glycoprotein

53
binding to HS moieties to gain neurovirulence (Ryman 2007; Gardner 2011,
2013). For the first time, it was shown that association with attachment factors
could potentially explain variance in tropism across the alphavirus species apart
from receptor binding, and the varying degrees of virulence within the same
virus.
We first wanted to observe if VEEV retaining E3 in a pH-dependent
manner can bind HS. Second, we attempted to show if this transient binding of
HS by E3 could allow the virus to alter tropism or impact entry. Taking advantage
of a recent putative receptor identified for SIND in the natural resistanceassociated macrophage protein (NRAMP2), we attempted to observe whether
VEEV was affected by downregulation of this receptor and whether virus
retaining E3 could then mitigate the effect (Rose 2011). Found in both
mammalian and insect cells, NRAMP is an iron transporter belonging to a class
of proteins that includes lactoferrin which influence the innate immune response
to viral infection through iron cation withdrawal (Nevo 2006; Johnson 2011).
There are two expressed types of NRAMP: The well-studied, primarily
intracellular NRAMP1, which functions in the immune response, and the
ubiquitously expressed homolog NRAMP2 located on cellular membranes. There
are 4 identified isoforms of NRAMP2 that arise from alternative splicing, and the
variant expressed is tissue specific and dependent on the presence of iron. The
prevalence of NRAMP2 in kidney epithelia and its upregulation in situations of
iron deficiency is well studied (Zhao 2012). In contrast, there is no known
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physiological sequestration of iron in mammalian cells so regulation of iron
uptake in instances when iron is abundant comes from the regulation of the
presence of NRAMP2 itself. Through supplementation of exogenous iron, cellsurface NRAMP2 is decreased through iron binding and uptake and initiates
feedback inhibition of the protein synthesis pathway for NRAMP production to
prevent excess uptake of cytotoxic levels of iron (Canonne-Hergaux 1999; Rose
2011). This novel mechanism of downregulating cell-surface NRAMP allows for
the investigation of the effects of VEEV E3 on entry using the NRAMP receptor.

4.3. Results
4.3.1. Entry of VEEV Retaining E3 in Cells Expressing Heparan Sulfate
The presence of HS moieties on the cell surface of targets was directly
investigated. Two cell lines, CHO 22 and CHO 18.4, were used to test the
importance of HS presence on E3 retention on mature VEEV virus. CHO 22
expresses HS at the cell surface whereas CHO 18.4 does not (Heil 2001). Virus
was produced as previously described in Chapter 2 using the aforementioned
Phoenix system in environmental conditions of pH 7.4 or pH 6.1 and applied to
target CHO 22 or CHO 18.4 cells in triplicate transduction assays. Viruses
transiently retaining E3 in a low pH-dependent manner are hypothesized to
convey an enhanced level of cellular transduction resulting from attachment of
E3 to heparan sulfate. This increased level of transduction is expected to be
minimized in experiments with target cells treated with heparinase.
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There was no observed significant change in transduction following
adjustment of pH for VSVG pseudotypes, however, there is a significant
decrease of transduction observed for SFV pseudotypes following treatment of
target CHO 22 cells by heparinase that is absent from CHO 18.4 cells lacking
native HS expression. This difference does not appear to be dependent on pH as
there is comparable levels of transduction for virus produced at pH 6.1 and pH
7.4 for both CHO cell lines.

4.3.2. Transduction of Target Cells Following Downregulation of NRAMP
Experiments targeting the downregulation of the NRAMP receptor were
performed in efforts to further observe whether the presence of the E3
glycoprotein improved the ability of virus to bind to and enter target cells lacking
a putative receptor. The hypothesis was that if E3 on mature VEEV could bind
HS and thus increase entry as seen in previous data, any observed decrease in
transduction levels due to a decrease in cell surface expression of NRAMP could
potentially be rescued by E3. Cells were treated with exogenous
supplementation of iron citrate prior to virus being applied. A rabbit polyclonal
antibody against mammalian NRAMP2 (Santa Cruz Biotech) was utilized in
assays to determine the successful downregulation of cell surface NRAMP in
target BHK cells that were treated for 72 hours as described in Chapter 2.
Validation of NRAMP2 expression was carried out alongside transduction
experiments with indirect-immunofluorescence and SDS-PAGE immunoblot
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assays and shows successful downregulation and overall decrease in both cellsurface and intracellular levels of NRAMP2 (Figure 16).
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4.3.3 Retention of E3 on VEEV Increases Entry after NRAMP2 Downregulation
Following downregulation of cell-surface NRAMP, it was found that entry
was rescued by the presence of the E3 glycoprotein on the surface of virus
targeting CHO 22 cells expressing HS on their surface. This increase in virus
entry is not seen for CHO 18.4 cells that lack HS and there is no significant
difference between CHO 22 and BHK cells for the heparinase experiments.
These findings were considered for target cells that had been treated with iron
citrate and thus underwent a downregulation of both cell-surface and intracellular
NRAMP2. The previous data showing a significant decrease in entry for VEEV in
target CHO cell lines provided an opportunity to use VEEV prepared as
previously described to retain E3 on the surface of mature virus. VEEV retaining
E3 in a pH-dependent manner was applied to target CHO 22 and CHO 18.4 cells
following treatment with 160 µM iron citrate for 72 hours (Figure 20).
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optimum infectivity or cell-dependent inhibition, the data suggests VEEV has
evolved a dual-role for the E3 glycoprotein. First, to protect the E1 fusion
envelope motif while maintaining stability during transport through an infected
cell. Second, to extend this electrostatic interaction and pH protection into the
extracellular matrix surrounding a cell as needed. Given the acidic environment
of viral infections that virus particles are budding into, it is plausible that this
auxiliary role for E3 has been selected for due to its additional binding
capabilities.
The results involving the increase of entry into cells containing heparan
sulfate support the hypothesis that the presence of E3 significantly affects the
entry of VEEV into CHO 22 cells expressing HS on their surface. The decrease
in transduction in CHO 18.4 cells by virus retaining E3 suggests, even transiently
associated E3 to E2, can inhibit entry and it is possible that the presence of HS
on CHO 22 cells rescues this inhibition by HS binding to E3 and potentially strips
it away from the virus. These findings support previous observations that pE2
cleavage-deficient SIND can establish HS binding and entry with resuscitating
mutations in E3 or E2 (Ryman 2004). Overall, the data shows an increase in
entry for virus retaining E3 to that of virus where E3 is absent in cell targets
expressing HS on their cell surface which is neutralized with heparinase to match
levels of entry observed for CHO 18.4 cells lacking cell-surface HS.
The utilization of the iron transporter protein NRAMP2 was an attempt to
use a defined receptor for alphavirus prototypic member SIND. Establishing its
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use in experiments to probe any effects of pH-dependent retention of the E3
glycoprotein on mature virus was supported first by the significant inhibition of
SIND pseudotypes that was not seen for RRV pseudotypes, and finally the
observed decrease in transduction of VEEV pseudotypes into target BHK and
CHO 22/18.4 cell lines. This decrease in entry levels was shown to be rescued
by virus prepared at pH 6.1 shown to retain E3 on mature virus particles. This
return of infectivity following downregulation of cell-surface and intracellular
NRAMP2 in CHO 22 (HS+) and CHO 18.4 (HS-) suggests that the retention of
E3 in low pH environments on mature virus particles could be selected for by
having an advantageous role in binding attachment factors such as HS.
These findings could explain the observed range of tropisms for alphavirus
members and also the expansion by some members into cells that leads to
increased virulence (Ryman 2007; Gardner 2011, 2013). A closer look at critical
residues within the sequence encoding E3 needs to be performed. Given the
sequence similarity between the various species of alphavirus, it is still not clear
if the increase in entry by cells with HS is occurring between E3 exclusively, by
residues shown to bind HS in E2, or a combination of both. Looking at the direct
binding of the E3 envelope glycoprotein to HS is necessary to identify the binding
characteristics of having it transiently associated.
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CHAPTER 5. INVESTIGATING THE EFFECTS OF LOW PH ON E3
RETENTION IN INSECT CELLS USING VEEV PSEUDOTYPE BACULOVIRUS

5.1. Abstract
Cell type is an important factor that should be considered when
investigating glycoprotein retention on mature arbovirus. The construction of
novel baculoviral pseudotypes was performed to express a replicationincompetent baculoviral core construct lacking the native gp64 envelope protein
that incorporates the alphaviral VEE envelope proteins on its surface. This was to
investigate the impacts of insect cell processing and membrane composition on
the low pH-dependent retention of VEEV E3 previously seen in mammalian cell
studies. Immunoblot analysis of envelope protein production and neutralization
studies with polyclonal antibodies against VEEV envelope proteins show similar
translation and envelope protein modification in Sf9 cells of infectious virus
comparable to mammalian cells, and a significant decrease in GFP reporter in
targeted Sf9 cells resulting from the inhibition in entry of virus produced at low pH
by E3 antibodies that is absent at higher pH for insect cells. These results
support previous findings showing infectious particles budding from insect cells
with differential processing of the pE2 glycoprotein from that of mammalian cells
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while remaining comparably infectious. This suggests that the higher level of pHdependent neutralization by polyclonal antibodies against E3 could potentially be
due to the more efficient cleavage of the pE2 polyprotein in insect cells and thus
more E3 readily available for retention at lower pH.

5.2. Introduction
Comparative studies across mammalian and insect cells have identified
differences in virus production and composition brought on by differences in the
cellular physiology of vectors. Epidemiological evidence of encephalitic viruses
like VEEV and arthralgia-causing pathogens like CHIKV and RRV has supported
a pattern of developing serological isotypes of enveloped viruses due to the type
of environment their emergence occurs in based on the vectors available for
production and spread (Kuno 2005; Solignat 2009). Phylogenic studies for
adaptive evolution contingent on hosts have identified selection occurring for
CHIKV and other Class II fusion viruses such as DENV that produces virus
capable of taking advantage of insect vector availability through key mutations in
the viral envelope spike broadening the range of tropism and membrane fusion
criteria (Bennett 2002; Tsetsarkin 2007; Dubrulle 2009). This selection potentially
differs amongst alphaviruses, and has been seen to be impacted by whether
virus can be transmitted vertically, but has the capacity to produce low
serological variance due to the ubiquitous prevalence of some of these viruses in
highly selective environments (Schuffenecker 2006; Vazeille 2009; Jones 2010).
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The importance of cellular membrane composition has also been
considered and well-studied for enveloped alphaviruses, encompassing
individual species member tropisms and cell-specific permissiveness. This stems
from the inherent differences between the insect vectors that have low levels of
sterol content used for transmission, and the incidental mammalian cell hosts
which are susceptible to the various species that are sterol-rich. The need for
cholesterol and sphingolipid in target cell membranes for both fusion and
successful budding has been observed for SFV, SIND, RRV, and CHIKV for
mammalian cell hosts with key mutations bypassing this need being observed in
both E1 and E2 glycoproteins (Strauss 1994; Lu 1999; Chatterjee 2000, 2002;
Kielian 2006; Tsetarkin 2007; Umashankar 2008). In cell passaging studies, the
differential incorporation of cholesterol into the lipid bilayer of budding alphavirus
species has been observed in mammalian and insect cells. This suggests that
the impact of target membrane composition on the success of virus entry and exit
is cell-type specific owning to the importance of cellular identity of the producing
cell to the viral envelope that buds from it (Hafer 2009).
The successful expression of proteins from vectors for gene payload
delivery or immunity priming have to consider the cell type in order to be
optimally effective due to differences in protein modification capabilities.
Consequentially, the differences between host cell types and their effect on
viruses are considered for medicinal aims of vectorology for both vaccine
development and gene therapy strategies (Kang 2002; Kahl 2005; Akahata
2010). For alphaviruses, differential processing of pE2 has been observed across
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mammalian and arthropod cell lines in that within arbovirus vectors, seen in A.
albopictus C6/36 cells, cleavage of pE2 in insect cells is more efficient than
mammalian cell lines (Heidner 1996). Indeed, this particular efficiency in pE2
cleavage is crucial for insect cells in order for virus to be infectious (Watson
1991). To further distinguish the neutralization of E3 in prior mammalian cell
studies; of retained E3 glycoprotein versus the percentage of virus particles
failing to cleave the pE2 polyprotein and presenting E3 a part of the spike
complex, we needed to investigate the retention of E3 in insect cells.
The PhoenixGP expression system employed for the mammalian cell
studies is unable to express within insect cells due to the specific mammalian
promoters RSV and CMV engineered within the genomic sequences that code
the gag/pol and alphaviral envelope protein genes, respectively. Previous
attempts with filovirus, rhabdovirus, and recently CHIKV E2-E1/Capsid proteins
have successfully demonstrated processing and infectivity of viral proteins and
establish the baculovirus expression system, a well-studied protein expression
system for both bacterial and insect cells, as a viable pseudotype vector system
in insect cell lines (Kitagawa 2004; Cho 2008; Westenberg 2010; Metz 2011; Kuo
2011; Laura Hughes-Baker thesis work). The utilization of an insect cell-based
expression system for pseudotype virus in insect cells would allow us to probe
the impacts of the differential processing of viral envelope proteins in insect cells
on the pH-dependent retention of the E3 glycoprotein.
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5.3. Results
5.3.1. Creation of VEEV Pseudotype Baculovirus
Bacmid constructs encoding the baculoviral core capsid either lacking the
native gp64 envelope protein (MW024) or containing gp64 as a wild-type control
(MW033) were graciously donated by the Dolphin group (Kings College, London,
UK). Virus budding from producer insect cells in either pH 7.4 or pH 6.1
conditions could potentially yield differences in E3 glycoprotein retention
accounting for cleavage and lipid membrane composition differences between
mammalian and insect cells. Following the transfection of producer Sf9 cells,
virus was harvested and the validation of viral envelope proteins from the
baculoviral pseudotypes was performed using SDS-PAGE and immunoblot
analysis with antibodies against VEEV E2/E1, E3, and the major baculoviral
capsid vp39 (a generous gift from Loy Volkman UC Berkeley) (Figure 22).
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5.3.2. Neutralization of VEEV Pseudotype Baculovirus by E3 Antibodies
VEEV pseudotype baculovirus produced following the transfection of
producer Sf9 cells was harvested after 96 hours and incubated with polyclonal
antibodies against E3, E2, or rabbit serum before being applied to target Sf9
insect cells. Target cells were assayed for reporter GFP expression 72 hours
later. There was a significant pH-dependent neutralization of infectious particles
incubated with polyclonal antibodies against E3 for virus prepared at pH 6.1 that
is absent for virus prepared at pH 7.4. This neutralization is significantly more
than that seen for samples treated with polyclonal antibodies against E2. There
was no significant effects on infection by pH adjustment or neutralization of virus
by rabbit serum at either pH (Figure 23).
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Figure 24. Neutralization of VEEV Pseudotyped Baculovirus in Sf9 Cells
The pH-dependent neutralization of VEEV pseudotype baculovirus was
performed in triplicate assays and is shown for target Sf9 insect cells transduced
by a GFP reporter following incubation of polyclonal antibodies at specified
dilutions. Error bars are standard deviation. Levels of inhibition are comparable to
mammalian studies.

5.4. Discussion
The differences in translational processing of the pE2 polyprotein for
alphaviruses between mammalian and insect cells was considered for VEEV.
Despite differences in the pH-dependent retention and neutralization of the E3
glycoprotein observed in mammalian producer cells using the Phoenix
expression system, those experiments cannot adequately distinguish between
species of pseudotype virus budding off with cleaved E3 that is retained through
the electrostatic association brought on by a low pH extracellular environment
from that of virus budding with a portion of the spike complexes as pE2-E1
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heterodimers (Figure 8). Indeed, a necessary distinction since the polyclonal
antibodies against E3 recognize both VEEV E3 and pE2. Insect cells have been
shown to contain a stricter requirement of pE2 cleavage for producing infectious
particles, and thus an efficient furin processing event of pE2. The amount of pHdependent neutralization of VEEV pseudotypes produced from insect cells would
therefore coincide with virus inhibited by antibodies binding cleaved E3 retained
at low pH and not of virus that contains pE2. The adoption of a baculovirus
expression system for expressing VEEV envelope proteins to investigate the
differences inherent between mammalian and insect cell translational machinery
shown here, for the first time, the successful expression of VEEV pseudotype
baculovirus.
The immunoblots of protein samples from VEEV pseudotype baculovirus
did not show recognition of E3 by antibody in virus pellets. Furthermore, unlike
what was observed for mammalian cells, there was a lack of signal for E3 as a
part of pE2 in producer cell lysate after probing with polyclonal antibodies against
E3 (Figure 22B, Lane 2). This could explain the absence of E3 in mature virus at
pH 6.1. Given the small 7kD size of E3, it is possible that the E3 glycoprotein is
at levels of production too low or the pseudotype virus titer is below the sensitivity
of the polyclonal antibodies. Despite this, the recognition of E2 and E1 by
polyclonal antibodies in virus pellets at either pH show virus production, and
coincide with the infectivity of these pseudotype particles seen by the
fluorescence of a GFP reporter following entry. This suggests that even with
levels of E3 protein too low to be recognized, infectious particles are still
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produced. The significant pH-dependent neutralization of viral entry by polyclonal
antibodies against E3 suggests that even though protein levels are low, it is
enough to bind to E2 and be neutralized by antibody.
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CHAPTER 6. CONCLUSIONS & FUTURE DIRECTIONS

6.1. Conclusions
The ability of Venezuelan equine encephalitis virus to retain the E3
glycoprotein on mature virus particles presents a unique capability by the virus to
protect the fusion epitope of E1 from the pH in the extracellular environment
outside of the producing cell it is budding from. The importance of this small, 7kD
glycoprotein has been slowly gaining attention. Data from recent studies
investigating key residue contacts between E2 and E3 support the critical
association of E3 required for the prevention of premature fusion and the
successful maturation of the E1 glycoprotein during intracellular transport (Lobigs
1990; Lescar 2001; Parrott 2009; Uchime 2013; Fields 2015; Swapna Apte thesis
work). This strategy is shared with other viruses using Class II fusion
mechanisms such as those belonging to flavivirus family. Dengue contains the
analogous prM and E proteins in which protection from premature fusion is
achieved by glycoprotein association extending on with mature virus (Guirakhoo
1992; Konishi 1992; Vazquez 2002; Mukhopadhyay 2005).
The association of E3 extending onto mature virus particles has limited
evidence supporting it. The data showing mice protected from a lethal challenge
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by VEEV following inoculation with monoclonal antibodies against E3 was the
first show neutralization of an alphavirus by antibodies against the E3
glycoprotein (Parker 2010). The ability for pH-dependent association between the
E3 glycoprotein and the E2-E1 heterodimer spike further supported the
importance of E3 processing and release from the envelope spike for SFV
(Sjoberg 2011). However, this work indirectly suggests that the extracellular
environment of the producing cell has influence on whether budding virus retains
the small 7kD E3 protein. As the viral pE2-E1 proteins are transported for
assembly and budding, the intracellular environment they move through
becomes progressively acidic. The temporal strategy for priming the furin
cleavage motif located between E3 and E2 is a necessary step to remove E3 and
prepare budding virus for infectivity while maintaining protection from low pH until
exit. Upon exit, however, despite the critical importance of a basic pH
maintenance in the lumen, the physiological relevance of a similar range of
acidity existing extracellularly during chronic, lytic infections or other disease
states with high occurrence of inflammation is considerable (Kim 1998; SanchezSan 2009). This could explain why neutralization of mature virus by antibodies
against E3 had been observed or why requirements of pE2 cleavage have been
found to differ by cell type (Heidner 1996; Parker 2010).
For years it was assumed that following a late-stage cleavage event by
cellular furin, E3 disassociates from E2, but specifically where and when this
separation takes place has not been fully understood. Recent work supports the
disassociation of E3 from mature virus particles outside the cell at neutral pH
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(Fields 2015). Structurally, major advances in the determination of the
conformational changes that the E2 and E1 glycoproteins undergo during fusion
at either neutral and acidic pH using CHIKV, SIND, and VEEV has shed more
light on the location of E3 with the envelope spike on mature virus (Li 2010; Voss
2010; Zhang 2011). However, retaining E3 on mature virus is detrimental to
infectivity (Bernard 2000; Sjoberg 2011; Gardner 2013; Swapna Apte thesis
work). Despite this detriment, cleaved E3 associated with E2 through pHdependent electrostatic associations could allow the virus to present new binding
sites for attachment, while permitting its removal from the envelope spike at
neutral pH to allow E2 to bind a receptor (Klimstra 1998, 1999; Li 2010; Parker
2010; Zhang 2011).
The utilization of pseudotyped virus in the studies described throughout
have allowed us to avoid the replication processes within the infectious pathway
of various viruses, including VEEV. This permitted the study of viral entry only
and prevented culture artifacts that have in the past been utilized as a tool to
investigate point mutations and amino acid adaptations from serial passaging
(Heidner 1996; Klimstra 1998; Tubulekas 1998; Heil 2001). Here, adaptation is
counter to the goal of identifying whether the wild-type TC-83 sequence of VEEV
envelope spike protein can facilitate the pH-dependent retention of the E3
glycoprotein at low pH. We show that indeed, at pH 6.5 or lower, MuLV
pseudotyped with VEEV envelope proteins retains E3 on budded, mature
particles as observed in neutralization assays and indirect-immunofluorescence
assays. This ability to bind to the envelope spike at low pH supports the
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observations with SFV mutants with E3 covalently associated to E2 (Sjoberg
2011). However, unlike the attenuation observed in permanent E3-E2
associations, this pH-dependent retention does not significantly affect the level of
entry for budded virus particles with E3 still associated. Furthermore, virus
budding into this extracellular pH transiently present residues in E3 for binding
interactions to occur, and should be considered at the same level of importance
as those interactions between E2 and receptors and attachment factors.

6.2. Future Directions
The ability of VEEV pseudotyped MuLV to retain the E3 glycoprotein on
budded particles in a pH-dependent manner is supported throughout the body of
work detailed, and is the first reported data showing E3 from infectious virus. The
significance of this retention is reflected in the studies investigating the effects of
E3 on mature virus as an attachment factor to target cells containing heparan
sulfate moieties. Mutations in the E2 glycoprotein have been observed to confer
attachment to heparan sulfate and permit an increase in both virulence and
tropism range for various alphaviruses (Klimstra 1998, 1999; Heil 2001; Ryman
2007; Zhu 2010; Gardner 2011, 2013). Essentially, the incorporation of
positively-charged residues within ectopic regions of the envelope spike protein
permits attachment to the negatively-charged sulfate groups on
glycosaminoglycans.
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The capability of the pE2 precursor protein to bind heparan sulfate has
been demonstrated using direct-binding studies with agarose beads investigating
the importance of the furin cleavage motif given its similarity to the consensus
sequences identified in heparan-sulfate binding (Klimstra 1998, 1999). Partial
deletions to the cleavage sequence on pE2 still showed binding to heparan
sulfate beads which has yet to be addressed in HS binding studies with virus
budding from mammalian cells with a low extracellular pH (Watson 1991;
Heidner 1996). In our work, we found that the neutralization of VEEV
pseudotypes by antibodies against E3 is much more pronounced in Sf9 insect
cells, which have a stricter cleavage requirement for infectious-capable virus and
thus will only retain E3 following cleavage if conditions of low pH are present
(Heidner 1996). This efficiency for furin cleavage seen in insect cells is absent for
mammalian cells that bud mature virus with an indefinite amount of pE2,
therefore it is necessary to determine which region of pE2 is responsible for
binding heparan sulfate if virus is budding in an extracellular environment of low
pH.

6.2.1. Results
Preliminary pull-down assays were performed using purified E3 protein
either containing (VEEV5A) or lacking (VEEV7B) the furin cleavage motif, and
purified VEEV virus produced IURPĭ1;JS cells at either pH 6.1, known to retain
E3, or pH 7.4 in which E3 disassociates. Samples were incubated with heparan-
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conclusion that virus transiently retaining E3 in a pH-dependent manner can
utilize heparan sulfate as an attachment factor in mammalian cells. This work
supports prior studies where infections from virus budding with a percentage of
pE2 can also bind heparan sulfate and significantly change the virulence
(Klimstra 1999; Ryman 2004).
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